Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study
ANNALS OF THE RHEUMATIC DISEASES（2019）
关键词
dmards (biologic),giant cell arteritis,systemic vasculitis,treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要